DE602004029061D1 - Zusammensetzungen, reagenzien, kits und verfahren für die diagnose und behandlung von fettleibigkeit und/oder diabetes - Google Patents
Zusammensetzungen, reagenzien, kits und verfahren für die diagnose und behandlung von fettleibigkeit und/oder diabetesInfo
- Publication number
- DE602004029061D1 DE602004029061D1 DE602004029061T DE602004029061T DE602004029061D1 DE 602004029061 D1 DE602004029061 D1 DE 602004029061D1 DE 602004029061 T DE602004029061 T DE 602004029061T DE 602004029061 T DE602004029061 T DE 602004029061T DE 602004029061 D1 DE602004029061 D1 DE 602004029061D1
- Authority
- DE
- Germany
- Prior art keywords
- diabetes
- kits
- reagents
- diagnosis
- gravity
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
- 206010012601 diabetes mellitus Diseases 0.000 title abstract 2
- 239000003153 chemical reaction reagent Substances 0.000 title 1
- 238000003745 diagnosis Methods 0.000 title 1
- 230000005484 gravity Effects 0.000 title 1
- 238000000034 method Methods 0.000 title 1
- 239000000203 mixture Substances 0.000 title 1
- 208000008589 Obesity Diseases 0.000 abstract 1
- 235000020824 obesity Nutrition 0.000 abstract 1
- 108090000623 proteins and genes Proteins 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/0004—Oxidoreductases (1.)
- C12N9/0006—Oxidoreductases (1.) acting on CH-OH groups as donors (1.1)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6879—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for sex determination
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Y—ENZYMES
- C12Y101/00—Oxidoreductases acting on the CH-OH group of donors (1.1)
- C12Y101/01—Oxidoreductases acting on the CH-OH group of donors (1.1) with NAD+ or NADP+ as acceptor (1.1.1)
- C12Y101/01146—11-Beta-hydroxysteroid dehydrogenase (1.1.1.146)
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S930/00—Peptide or protein sequence
- Y10S930/01—Peptide or protein sequence
- Y10S930/12—Growth hormone, growth factor other than t-cell or b-cell growth factor, and growth hormone releasing factor; related peptides
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Zoology (AREA)
- Genetics & Genomics (AREA)
- Engineering & Computer Science (AREA)
- Wood Science & Technology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Health & Medical Sciences (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biochemistry (AREA)
- General Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Medicinal Chemistry (AREA)
- Analytical Chemistry (AREA)
- Microbiology (AREA)
- Biotechnology (AREA)
- Biophysics (AREA)
- Immunology (AREA)
- Physics & Mathematics (AREA)
- Diabetes (AREA)
- Toxicology (AREA)
- Pathology (AREA)
- Biomedical Technology (AREA)
- Gastroenterology & Hepatology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Public Health (AREA)
- Hematology (AREA)
- Animal Behavior & Ethology (AREA)
- Obesity (AREA)
- Pharmacology & Pharmacy (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Veterinary Medicine (AREA)
- Endocrinology (AREA)
- Child & Adolescent Psychology (AREA)
- Emergency Medicine (AREA)
- Peptides Or Proteins (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US10/659,782 US7176292B2 (en) | 2003-09-11 | 2003-09-11 | Ghrelin variant protein |
| PCT/US2004/029230 WO2005026392A2 (en) | 2003-09-11 | 2004-09-09 | Compositions, reagents and kits for and methods of diagnosing, monitoring and treating obesity and/or diabetes |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DE602004029061D1 true DE602004029061D1 (de) | 2010-10-21 |
Family
ID=34273528
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DE602004029061T Expired - Lifetime DE602004029061D1 (de) | 2003-09-11 | 2004-09-09 | Zusammensetzungen, reagenzien, kits und verfahren für die diagnose und behandlung von fettleibigkeit und/oder diabetes |
Country Status (14)
| Country | Link |
|---|---|
| US (2) | US7176292B2 (https=) |
| EP (1) | EP1664346B1 (https=) |
| JP (2) | JP2007504825A (https=) |
| KR (1) | KR101081040B1 (https=) |
| CN (1) | CN101023184A (https=) |
| AT (1) | ATE480641T1 (https=) |
| AU (2) | AU2004273053B2 (https=) |
| BR (1) | BRPI0414365A (https=) |
| CA (1) | CA2538514C (https=) |
| DE (1) | DE602004029061D1 (https=) |
| IL (2) | IL174195A (https=) |
| NZ (1) | NZ546488A (https=) |
| RU (1) | RU2420583C2 (https=) |
| WO (1) | WO2005026392A2 (https=) |
Families Citing this family (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US8512971B2 (en) * | 2002-12-10 | 2013-08-20 | Echelon Biosciences, Inc. | Compounds and methods of use thereof for assaying lysophospholipase D activity |
| US20050208658A1 (en) * | 2003-11-21 | 2005-09-22 | The University Of Maryland | RNA interference mediated inhibition of 11beta hydroxysteriod dehydrogenase-1 (11beta HSD-1) gene expression |
| EP1747264B1 (de) | 2004-05-21 | 2012-09-12 | Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung e.V. | Multizelluläre gewebe- und organkultursysteme |
| WO2005119525A1 (en) * | 2004-06-04 | 2005-12-15 | Pfizer Products Inc. | 11βHSD1 CRYSTAL STRUCTURES FOR STRUCTURE BASED DRUG DESIGN |
| WO2007055996A2 (en) * | 2005-11-03 | 2007-05-18 | Liat Mintz | Compositions, reagents and kits for and methods of diagnosing, monitoring and treating hormonal imbalance |
| NZ571183A (en) * | 2006-03-13 | 2010-09-30 | Liat Mintz | Use of ghrelin splice variant for treating cachexia and/or anorexia and/or anorexia-cachexia and/or malnutrition and/or lipodystrophy and/or muscle wasting and/or appetite stimulation |
| US7763707B2 (en) * | 2006-03-13 | 2010-07-27 | Liat Mintz | Use of ghrelin splice variant for treating cachexia and/or anorexia and/or anorexia-cachexia and/or malnutrition and/or lipodystrophy and/or muscle wasting and/or appetite-stimulation |
| WO2007126792A2 (en) * | 2006-03-28 | 2007-11-08 | Liat Mintz | Use of ghrelin splice variant for treating high cholesterol levels or high plasma glucose levels and releated diseases |
| WO2009048903A1 (en) * | 2007-10-08 | 2009-04-16 | Bristol-Myers Squibb Company | 11 beta hydroxysteroid dehydrogenase type 1 |
| JP2011516038A (ja) * | 2008-03-12 | 2011-05-26 | オタゴ イノベーション リミテッド | バイオマーカー |
| ES2372337B1 (es) * | 2010-06-10 | 2013-01-18 | Servicio Andaluz De Salud | Variante de la ghrelina y sus usos. |
| WO2013113916A2 (en) * | 2012-02-03 | 2013-08-08 | Zealand Pharma A/S | Ghrelin analogues |
| CN102721819B (zh) * | 2012-06-28 | 2014-08-13 | 广州瑞博奥生物科技有限公司 | 一种脂联素的竞争抑制性酶联免疫检测试剂盒及方法 |
| US20190316204A1 (en) * | 2015-07-24 | 2019-10-17 | Korea University Research And Business Foundation | Biomarker for determining aging, determining obesity, and diagnosing cancer and diagnosing kit using same |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6291653B1 (en) * | 1997-03-24 | 2001-09-18 | Zymogenetics, Inc. | Antibodies to motilin homologs |
| US20040023874A1 (en) * | 2002-03-15 | 2004-02-05 | Burgess Catherine E. | Therapeutic polypeptides, nucleic acids encoding same, and methods of use |
| US6967237B2 (en) | 2000-05-30 | 2005-11-22 | Merck & Co., Inc. | Ghrelin analogs |
| DK1426764T3 (da) * | 2001-08-17 | 2011-06-27 | Fujirebio Kk | Fremgangsmåde til diagnosticering eller monitorering af fejl i sukkermetabolisme |
| EP1458758A2 (en) * | 2001-12-21 | 2004-09-22 | Maxygen Aps | Adiponectin fragments and conjugates |
| AU2002364586A1 (en) * | 2001-12-21 | 2003-07-30 | Delta Biotechnology Limited | Albumin fusion proteins |
| WO2003059934A2 (en) * | 2001-12-21 | 2003-07-24 | Human Genome Sciences, Inc. | Albumin fusion proteins |
| CA2473781A1 (en) * | 2002-01-18 | 2003-07-31 | Protemix Corporation Limited | Glycoisoforms of adiponectin and uses thereof |
| JPWO2003063894A1 (ja) * | 2002-01-31 | 2005-05-26 | 独立行政法人科学技術振興機構 | インスリン抵抗性改善剤 |
| NZ571183A (en) * | 2006-03-13 | 2010-09-30 | Liat Mintz | Use of ghrelin splice variant for treating cachexia and/or anorexia and/or anorexia-cachexia and/or malnutrition and/or lipodystrophy and/or muscle wasting and/or appetite stimulation |
-
2003
- 2003-09-11 US US10/659,782 patent/US7176292B2/en not_active Expired - Lifetime
-
2004
- 2004-09-09 CA CA2538514A patent/CA2538514C/en not_active Expired - Fee Related
- 2004-09-09 BR BRPI0414365-5A patent/BRPI0414365A/pt not_active IP Right Cessation
- 2004-09-09 AT AT04783470T patent/ATE480641T1/de not_active IP Right Cessation
- 2004-09-09 WO PCT/US2004/029230 patent/WO2005026392A2/en not_active Ceased
- 2004-09-09 RU RU2006111720/10A patent/RU2420583C2/ru not_active IP Right Cessation
- 2004-09-09 EP EP04783470A patent/EP1664346B1/en not_active Expired - Lifetime
- 2004-09-09 JP JP2006526255A patent/JP2007504825A/ja active Pending
- 2004-09-09 KR KR1020067004972A patent/KR101081040B1/ko not_active Expired - Fee Related
- 2004-09-09 NZ NZ546488A patent/NZ546488A/en not_active IP Right Cessation
- 2004-09-09 DE DE602004029061T patent/DE602004029061D1/de not_active Expired - Lifetime
- 2004-09-09 CN CNA2004800262032A patent/CN101023184A/zh active Pending
- 2004-09-09 AU AU2004273053A patent/AU2004273053B2/en not_active Ceased
-
2006
- 2006-03-09 IL IL174195A patent/IL174195A/en not_active IP Right Cessation
- 2006-10-13 US US11/580,472 patent/US8088730B2/en not_active Expired - Lifetime
-
2009
- 2009-07-28 IL IL200120A patent/IL200120A0/en unknown
-
2010
- 2010-08-20 AU AU2010212460A patent/AU2010212460A1/en not_active Abandoned
- 2010-12-01 JP JP2010268513A patent/JP5314658B2/ja not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| CN101023184A (zh) | 2007-08-22 |
| WO2005026392A2 (en) | 2005-03-24 |
| RU2006111720A (ru) | 2007-10-20 |
| US20050059015A1 (en) | 2005-03-17 |
| WO2005026392A3 (en) | 2005-08-11 |
| JP5314658B2 (ja) | 2013-10-16 |
| ATE480641T1 (de) | 2010-09-15 |
| NZ546488A (en) | 2009-01-31 |
| US20070086997A1 (en) | 2007-04-19 |
| US7176292B2 (en) | 2007-02-13 |
| JP2007504825A (ja) | 2007-03-08 |
| EP1664346B1 (en) | 2010-09-08 |
| US8088730B2 (en) | 2012-01-03 |
| IL174195A0 (en) | 2006-08-01 |
| AU2004273053A1 (en) | 2005-03-24 |
| HK1092841A1 (en) | 2007-02-16 |
| CA2538514C (en) | 2014-04-08 |
| AU2010212460A1 (en) | 2010-09-09 |
| BRPI0414365A (pt) | 2006-11-14 |
| JP2011182776A (ja) | 2011-09-22 |
| IL174195A (en) | 2012-08-30 |
| IL200120A0 (en) | 2011-08-01 |
| KR101081040B1 (ko) | 2011-11-09 |
| AU2004273053B2 (en) | 2010-05-20 |
| KR20060083208A (ko) | 2006-07-20 |
| CA2538514A1 (en) | 2005-03-24 |
| EP1664346A2 (en) | 2006-06-07 |
| RU2420583C2 (ru) | 2011-06-10 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL200120A0 (en) | Compositions, reagents and kits for and methods of diagnosing, monitoring and treating obesity and/or diabetes | |
| ATE470723T1 (de) | Genexpressionsmarker für die prognose von brustkrebs | |
| ATE528410T1 (de) | Verfahren und zusammensetzungen zur diagnose von altersbedingter maculadegeneration | |
| ATE310955T1 (de) | Zusammensetzungen und verfahren zum nachweis und zur behandlung von mit chemokinrezeptoren verbundenen krankheiten | |
| ATE544748T1 (de) | Zusammensetzungen und verfahren für die behandlung von zellproliferationserkrankungen | |
| ATE424560T1 (de) | Marker für neuromyelitis optica | |
| ATE439868T1 (de) | Targetingmittel für molekulare bilderzeugung | |
| DE112005002742A5 (de) | Verbindungen und Methoden zur Behandlung, Diagnose und Prognose bei Pankreasererkrankungen | |
| ATE526991T1 (de) | Zusammensetzungen und ihre verwendungen für die gentherapeutische behandlung von knochenerkrankungen | |
| EP1583504A4 (en) | METHOD AND COMPOSITIONS FOR DIAGNOSIS, FORECAST AND TREATMENT OF CANCER | |
| DE602004023721D1 (de) | Zusammensetzungen und methoden für die behandlung von herzerkrankungen | |
| ATE422671T1 (de) | Verfahren zur diagnose von morbus alzheimer | |
| DE60126248D1 (de) | Verwendung von brustkrebs membranproteine für behandlung, prophylaxe und diagnose von brustkrebs | |
| ATE462702T1 (de) | Für die behandlung von entzündlichen krankheiten nützliche beta-carboline | |
| ATE490339T1 (de) | Diagnostikum für osteoporose | |
| BRPI0512745A (pt) | métodos de genotipagem e de caracterizar um agente e kit | |
| DE60325194D1 (de) | Methoden zur verwendung von lamellaren körpern für therapeutische zwecke | |
| EA200600012A1 (ru) | Полиморфизм человеческого гена nbs1, полезный для диагностики наследственной предрасположенности к раку | |
| DE50301549D1 (de) | Verfahren und Prüfstand für Schwingungs-, Akustik- und/oder Funktionsuntersuchungen von Getrieben | |
| ATE442382T1 (de) | Ein die mam-domäne enthaltendes protein | |
| DE502004002460D1 (de) | Verwendung von copolymerisaten als hilfsmittel für die lederherstellung | |
| DE602005013287D1 (de) | Zusammensetzung zur behandlung von leder | |
| DE60225845D1 (de) | Zusammensetzungen und verfahren zur diagnose und behandlung von diabetes, insulinresistenz und dyslipidämie | |
| ATE482180T1 (de) | Verfahren zur herstellung von 3,5- bis(trifluormethyl)-n-methylbenzylamin | |
| SG146459A1 (en) | Compositions, reagents and kits for and methods of diagnosing, monitoring and treating obesity and/or diabetes |